Lead Generation for Vendors Selling Prior-Auth Software to Infusion Clinics

Independent infusion clinics and specialty infusion centers administer high-cost biologic and IV therapies that almost always require prior authorization before treatment, and many patients also need enrollment in a drug manufacturer’s copay assistance program to afford it at all. Vendors selling prior-auth and copay-enrollment automation software are chasing a real, painful problem, but a lot of outreach in this space is really written for hospital billing departments - and an infusion clinic is a completely different buyer with none of that department’s resources.

No billing department to hide the problem

A hospital has a dedicated revenue cycle team that absorbs prior-auth and copay complexity, even if inefficiently. A standalone infusion clinic usually has a practice administrator or a small front-office team handling this by hand, alongside scheduling, intake, and everything else running the clinic. When a prior auth or copay enrollment lags, there’s no backstop team to catch it - the patient’s treatment start gets delayed, or the clinic eats the cost of a drug that isn’t yet authorized. That’s a sharper, more immediate pain than the version of this problem hospital-focused vendors usually pitch to.

Every biologic has its own rulebook

This isn’t one generic prior-authorization workflow - each biologic drug typically has its own manufacturer copay program, its own enrollment forms, and its own eligibility rules, and clinics often administer a handful of different high-cost therapies at once. A vendor that pitches “automate your prior authorizations” as a single generic workflow misses that the actual daily pain is juggling several different rule sets for different drugs, often on paper, with no system tracking which patient is enrolled in which program.

Speed to treatment is the outcome that matters

For an infusion clinic, the metric that actually justifies buying software isn’t “hours saved on admin” in the abstract - it’s how much faster a patient can start treatment once it’s prescribed. A clinic administrator can take “patients start treatment X days faster” to a physician group or clinic owner in a way that a generic efficiency number doesn’t land the same way. Vendors who lead with treatment-start speed, not admin time saved, are speaking to what this buyer is actually being measured on.

What a working process looks like

1. Target practice administrators and clinic managers directly, not hospital revenue-cycle titles - this is a fundamentally different buyer with different resources.
2. Lead with the per-drug complexity of copay enrollment, since that’s the specific daily pain, not a generic “prior authorization” pitch.
3. Frame the outcome as speed to treatment start, since that’s the number this buyer can actually use to justify the purchase upward.
4. Keep messaging separate from hospital-focused positioning entirely, since a small independent clinic reads hospital-scale language as not built for them.

How Fypion approaches this

For clients selling prior-authorization and copay-assistance automation into infusion clinics, we build outreach around the practice administrator’s actual daily reality - juggling different rules for different biologics with no dedicated billing team - rather than repurposing a hospital-focused pitch. We lead with speed to treatment start as the outcome, since that’s what this buyer can take to their own leadership to justify the purchase.

Talk to us if your outbound to infusion clinics is reading like a hospital pitch aimed at a buyer who isn’t one.